Loading...
ICIs治疗晚期非小细胞肺癌免疫相关不良事件的系统综述及Meta分析
BACKGROUND AND OBJECTIVE: In recent years, immune checkpoint inhibitors (ICIs) have become a hot spot in cancer because of their remarkable survival benefits on non-small cell lung cancer (NSCLC) patients. However, the immune-related adverse events (ir-AEs) induced by ICIs have been frequently repor...
Na minha lista:
| Udgivet i: | Zhongguo Fei Ai Za Zhi |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
中国肺癌杂志编辑部
2020
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7519956/ https://ncbi.nlm.nih.gov/pubmed/32752580 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3779/j.issn.1009-3419.2020.104.07 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|